Skip to main content
Caplight Logo









ClearNote Health

ClearNote Health

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.clearnotehealth.com/

Last Round

Series D

May 27, 2026

Total Funding Raised

$143.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ClearNote Health is a biotechnology company that develops non-invasive blood tests to detect high-mortality cancers at an early stage.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

liquid biopsyearly cancer detectionepigenomics5hmC analysispancreatic cancer testcell-free DNAcfDNAepigenetic biomarkersovarian cancer testbiopharma servicesmulti-cancer detectionMCEDmachine learning diagnosticstherapy response monitoringCLIA certified lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ClearNote Health Comparables

Compare ClearNote Health with similar companies based on industry and business-model similarity.

ClearNote Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adela
82%
Singlera Genomics Inc.
82%
Mercy BioAnalytics
82%

ClearNote Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 27, 2026
Series DJun 5, 2025
Series CMay 12, 2021

Key People

Founding team and executive leadership

Kevin Keegan

Chief Executive Officer

Executive Team

ClearNote Health Investors

Notable investors and investment history

ClearNote Health investors
InvestorRounds
Prosperity Capital ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    $52M round led by Mattias Westman

  • Sep 18, 2025

    Partnered with BCAL Diagnostics Limited to integrate diagnostic technology.

ClearNote Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ClearNote Health Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Diego, California
Employee Range59
Year Founded2016
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?